Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

KPMG Speaks On What 2022 Medtech Investment May Look Like

Executive Summary

2021 was a busy year in the medtech investment space. How will 2022 compare?

You may also be interested in...



Shortsellers Say Gingko BioWorks Is ‘Colossal Synthetic Biology Scam'

The company claims its synthetic biology technology will revolutionize manufacturing but its share have dipped after the fraud allegations.

Pandemic Perspectives: A Lasting Impact On Medtech, But Not Dealmaking

The COVID-19 pandemic has fundamentally changed health care and the life sciences, KPMG analyst Kristin Pothier concludes in a new report on the medtech investment outlook.

Hologic Continues Spending Spree With $230M Tuck-In Acquisition Of Biotheranostics

Hologic’s recent buy-outs put it in a strengthened growth and competitive position beyond COVID.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT145078

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel